bioMérieux launches 3P® ENTERPRISE, an innovative solution to address the daily challenges of environmental monitoring in the pharma industry

Launch of BIOFIRE® MYCOPLASMA Test for Mycoplasma Detection in Biopharmaceutical Products

bioMérieux Receives FDA Clearance to Extend Platelet Shelf Life to 7 Days with Large Volume Delayed Sampling Strategy Using BACT/ALERT® 3D and BACT/ALERT® VIRTUO® Culture Systems.

bioMérieux Receives Innovation Award from French-American Chamber of Commerce